User:Mary Mendoza/Notebook/CHEM572 Exp. Biological Chemistry II/2013/03/20: Difference between revisions
From OpenWetWare
Mary Mendoza (talk | contribs) |
Mary Mendoza (talk | contribs) |
||
(One intermediate revision by the same user not shown) | |||
Line 13: | Line 13: | ||
* The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated. | * The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated. | ||
* Kaempferol trials were started. | * Kaempferol trials were started. | ||
* After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM. | * After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM. In addition, cuvettes will also contain 300 μL of DMSO. | ||
* For the following week, a new aspiring stock solution will be prepared. | |||
==adenosine vs. aspirin== | ==adenosine vs. aspirin== | ||
* The histogram below displays the non-inhibitory effect of aspirin. | |||
[[Image: | [[Image:Bar2.png]] | ||
==Tables== | ==Tables== |
Revision as of 17:56, 22 March 2013
Project name | <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page <html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html> </html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html> |
Histogram
adenosine vs. aspirin
Tables
|